Showing results (231-240 of 444) with videos related to

Sort By:
Pageof 45
American Journal of Respiratory and Critical Care Medicine|November 29, 2023
Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator ResponsivenessRichard Beasley, Rod Hughes, Alvar Agusti, et al.
Respiratory Medicine|December 25, 2025
Allergic sensitization in asthma and COPD in the NOVELTY studyChrister Janson, Andrei Malinovschi, Magnus Borres, et al.
Current Respiratory Care Reports|November 9, 2012
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohortBradley E Chipps, Robert S Zeiger, Alejandro Dorenbaum, et al.
Sarcoidosis, Vasculitis, and Diffuse Lung Diseases : Official Journal of WASOG|May 10, 2003
Increased proportion of CD8+ T-lymphocytes in the paratracheal lymph nodes of smokers with mild COPDMarina Saetta, Simonetta Baraldo, Graziella Turato, et al.
The European Respiratory Journal|April 12, 2024
The carbon footprint of as-needed budesonide/formoterol in mild asthma: a post hoc analysisLee Hatter, Mark Holliday, Allie Eathorne, et al.
ERJ Open Research|February 13, 2024
The many faces of COPD in real life: a longitudinal analysis of the NOVELTY cohortAlvar Agustí, Rod Hughes, Eleni Rapsomaki, et al.
Pulmonary Pharmacology & Therapeutics|February 15, 2005
Sputum substance P and neurokinin A are reduced during exacerbations of chronic obstructive pulmonary diseasePiera Boschetto, Deborah Miotto, Ilaria Bononi, et al.
Primary Care Respiratory Journal : Journal of the General Practice Airways Group|November 5, 2013
Clinical and cost effectiveness of switching asthma patients from fluticasone-salmeterol to extra-fine particle beclometasone-formoterol: a retrospective matched observational study of real-world patientsDavid Price, Iain Small, John Haughney, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 5, 2022
Evaluating construct validity of the Asthma Impairment and Risk Questionnaire using a 3-month exacerbation recallBradley E Chipps, Kevin R Murphy, Robert A Wise, et al.
The Journal of Allergy and Clinical Immunology. in Practice|May 5, 2024
Impact of Clinical Characteristics and Biomarkers on Asthma Impairment and Risk Questionnaire Exacerbation Prediction AbilityKevin R Murphy, David A Beuther, Bradley E Chipps, et al.
Pageof 45